State Street’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

State Street’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,527,235	Closed	-$23.5M	–	4522
2023 Q3	$23.5M	Buy	3,527,235 +131,083	+4%	+$1.09M	﹤0.01%	2066
2023 Q2	$30.8M	Buy	3,396,152 +274,757	+9%	+$2.42M	﹤0.01%	1966
2023 Q1	$22.7M	Sell	3,121,395 -1,164,862	-27%	-$8.64M	﹤0.01%	2139
2022 Q4	$31.2M	Buy	4,286,257 +1,277,089	+42%	+$9.48M	﹤0.01%	1935
2022 Q3	$23.3M	Buy	3,009,168 +791,372	+36%	+$6.72M	﹤0.01%	2110
2022 Q2	$15.1M	Buy	2,217,796 +1,947,859	+722%	+$14.9M	﹤0.01%	2441
2022 Q1	$2.15M	Buy	269,937 +17,245	+7%	+$109K	﹤0.01%	3536
2021 Q4	$1.42M	Buy	252,692 +26,292	+12%	+$197K	﹤0.01%	3736
2021 Q3	$1.74M	Buy	+226,400	New	+$2.07M	﹤0.01%	3644

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

State Street's PNT Position: Q4 2023 in Review

State Street sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 3,527,235 shares — an estimated $23.5M sold.

State Street first reported a position in PNT in Q3 2021 and held it in 9 quarters. The position peaked at $31.2M in Q4 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

State Street reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
State Street sold 3,527,235 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $23.5M.
State Street first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2021 and held it in 9 quarters.
State Street's POINT Biopharma Global Inc. Common Stock position peaked at $31.2M in Q4 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.